- Home
- SOPH vs NBTX Comparison
SOPH vs NBTX Comparison
Compare SOPH & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOPH | NBTX |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | Switzerland | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.7M | 1.0B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SOPH | NBTX |
|---|---|---|
| Price | $5.01 | $32.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $7.00 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 96.8K | 40.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.16 | N/A |
| Revenue Next Year | $17.56 | $11.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.58 | $2.99 |
| 52 Week High | $5.70 | $41.89 |
Technical Indicators
Market Signals| Indicator | SOPH | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 63.44 | 53.81 |
| Support Level | $4.54 | $20.11 |
| Resistance Level | $5.30 | $41.89 |
| Average True Range (ATR) | 0.31 | 2.90 |
| MACD | 0.07 | -0.28 |
| Stochastic Oscillator | 92.69 | 37.37 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.